Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M--Revenue $M--Net Margin (%)--Altman Z-Score
Enterprise Value $M--EPS $--Operating Margin %--Piotroski F-Score--
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio--Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %ROA % (ttm)--Higher Current Ratio y-yN
Dividend Yield %--PEG1.2ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M--ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with GCVRZ

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
GCVRZMario Gabelli 2015-03-31 Reduce$0.6 - $0.81
($0.7)
$ 0.734%Reduce 58.50%74,431
GCVRZMario Gabelli 2014-12-31 Reduce$0.47 - $0.87
($0.61)
$ 0.7320%Reduce 40.88%179,351
GCVRZFirst Eagle Investment 2014-12-31 Reduce$0.47 - $0.87
($0.61)
$ 0.7320%Reduce 35.34%146,402
GCVRZMichael Price 2014-09-30 Reduce-0.24%$0.45 - $0.51
($0.49)
$ 0.7349%Reduce 75.83%1,275,000
GCVRZMario Gabelli 2014-09-30 Reduce$0.45 - $0.51
($0.49)
$ 0.7349%Reduce 45.86%303,351
GCVRZMario Gabelli 2014-03-31 Reduce$0.3 - $0.47
($0.37)
$ 0.7397%Reduce 35.10%631,351
GCVRZMichael Price 2013-12-31 Add0.06%$0.32 - $2.04
($1.21)
$ 0.73-40%Add 31.68%5,300,000
GCVRZFirst Eagle Investment 2013-12-31 Add$0.32 - $2.04
($1.21)
$ 0.73-40%Add 16262.50%229,402
GCVRZWhitney Tilson 2013-09-30 Add0.1%$1.82 - $2.04
($1.9)
$ 0.73-62%Add 62.20%81,100
GCVRZMichael Price 2012-03-31 Add0.19%$1.25 - $1.37
($1.22)
$ 0.73-40%Add 29.41%4,400,000
GCVRZFirst Eagle Investment 2011-12-31 Reduce$0.89 - $1.34
($1.12)
$ 0.73-35%Reduce 99.53%1,402
GCVRZMichael Price 2011-09-30 Add0.26%$0.99 - $2.56
($1.4)
$ 0.73-48%Add 70.00%3,400,000
GCVRZFirst Eagle Investment 2011-09-30 Reduce-0.01%$0.99 - $2.56
($1.4)
$ 0.73-48%Reduce 81.30%301,402
GCVRZMichael Price 2011-06-30 Buy 0.7%$2.29 - $2.63
($2.44)
$ 0.73-70%New holding2,000,000
GCVRZMario Gabelli 2011-06-30 Buy 0.04%$2.29 - $2.63
($2.44)
$ 0.73-70%New holding2,288,150
GCVRZFirst Eagle Investment 2011-06-30 Buy 0.02%$2.29 - $2.63
($2.44)
$ 0.73-70%New holding1,611,585
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

GCVRZ is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


GCVRZ: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Press Releases about GCVRZ :

    Quarterly/Annual Reports about GCVRZ:

      News about GCVRZ:

      Articles On GuruFocus.com

      More From Other Websites
      PureTech looks to raise $160m with London listing May 26 2015
      Amgen first to win EU backing for new kind of cholesterol drug May 22 2015
      Hedge fund firm Man Group feels investor backlash on pay May 08 2015
      Form 20F for Sanofi Mar 17 2015
      Heart drugs take center stage Mar 16 2015
      Long-term use of AstraZeneca heart drug brings benefits, some risks Mar 14 2015
      The Isa funds tipped to shine until 2020 Mar 13 2015
      Unilife's unique delivery systems Feb 10 2015
      QE also means free lunch for multinationals Feb 08 2015
      Europe open: Stocks slide as ECB restricts loans and Greece sticks to anti-austerity demands Feb 05 2015
      European shares fall after ECB decision on Greek debt Feb 05 2015
      Europe shares fall after ECB decision on Greek debt Feb 05 2015
      Gates, UK take lead in $7.5 bln pledge for children's vaccines Jan 27 2015
      Incoming Takeda CEO ready to do deals after refocusing drug company Jan 21 2015
      Britain's health service to halt access to some costly cancer drugs Jan 12 2015
      Lufthansa leads European stock bounce as oil slump boosts profit Jan 12 2015
      European stocks rise, buoyed by chemical and health shares Jan 12 2015
      Rise in healthcare stocks lifts European equities Jan 12 2015
      'Outrage' Over Plans To Drop Cancer Drugs Jan 12 2015
      France's Sanofi to start production in Saudi Dec 11 2014

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      FEEDBACK